EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut Protective Effect from D-Methionine or Butyric Acid against DSS and Carrageenan-Induced Ulcerative Colitis

Yuka Ikeda iD, Satoru Matsuda iD

Molecules · 2023

DOI: 10.3390/molecules28114392 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Yuka Ikeda und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science and Nutrition, Nara Women's University, Kita-Uoya Nishimachi, Nara 630-8506, Japan. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Inflammatory Bowel Diseases, Colitis. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microbiome dysbiosis resulting in altered metabolite profiles may be associated with certain diseases, including inflammatory bowel diseases (IBD), which are characterized by active intestinal inflammation. Several studies have indicated the beneficial anti-inflammatory effect of metabolites from gut microbiota, such as short-chain fatty acids (SCFAs) and/or D-amino acids in IBD therapy, through orally administered dietary supplements. In the present study, the potential gut protective effects of d-methionine (D-Met) and/or butyric acid (BA) have been investigated in an IBD mouse model. We have also built an IBD mouse model, which was cost-effectively induced with low molecular weight DSS and kappa-carrageenan. Our findings revealed that D-Met and/or BA supplementation resulted in the attenuation of the disease condition as well as the suppression of several inflammation-related gene expressions in the IBD mouse model. The data shown here may suggest a promising therapeutic potential for improving symptoms of gut inflammation with an impact on IBD therapy. However, molecular metabolisms need to be further explored.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeInflammatory Bowel DiseasesColitisMiceAnimalsCarrageenanMethionineButyric AcidInflammationRacemethionineDextran SulfateDisease Models, AnimalMice, Inbred C57BL

Stichwörter der Autor:innen

D-amino acidsD-methioninebutyric acidinflammatory bowel diseasepostbioticsshort chain fatty acidsulcerative colitis

Substanzen

CarrageenanMethionineButyric AcidRacemethionineDextran Sulfate

Autor:innen und Institutionen

  • Department of Food Science and Nutrition, Nara Women's University, Kita-Uoya Nishimachi, Nara 630-8506, Japan.

ORCID-Profile: Yuka Ikeda, Satoru Matsuda

Zitieren

APA

Ikeda, Y., & Matsuda, S. (2023). Gut Protective Effect from D-Methionine or Butyric Acid against DSS and Carrageenan-Induced Ulcerative Colitis. Molecules. https://doi.org/10.3390/molecules28114392

Vancouver

Ikeda Y, Matsuda S. Gut Protective Effect from D-Methionine or Butyric Acid against DSS and Carrageenan-Induced Ulcerative Colitis. Molecules. 2023. doi:10.3390/molecules28114392

BibTeX
@article{Ikeda2023,
  author = {Ikeda, Yuka and Matsuda, Satoru},
  title = {Gut Protective Effect from D-Methionine or Butyric Acid against DSS and Carrageenan-Induced Ulcerative Colitis},
  journal = {Molecules},
  year = {2023},
  doi = {10.3390/molecules28114392}
}
Kostenlos starten →